Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call Transcript

Core Viewpoint - Co-Diagnostics, Inc. reported its financial results for Q2 2025, highlighting developments in its Co-Dx PCR testing platform and the need for regulatory approval before market availability [2][3]. Financial Results - The company released its financial results for the second quarter ended June 30, 2025, which are available on its website [2]. Management Remarks - The conference call included prepared remarks from the CEO Dwight Egan and CFO Brian Brown, followed by a Q&A session with analysts [2]. Forward-Looking Statements - The company made forward-looking statements regarding its Co-Dx PCR testing platform, emphasizing that it requires regulatory approval and is not currently for sale [3][4].